One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial

ExTRACT-TIMI 25 Investigators, David A Morrow, Elliott M Antman, Keith A A Fox, Harvey D White, Robert Giugliano, Sabina A Murphy, Carolyn H McCabe, Eugene Braunwald

Research output: Contribution to journalArticlepeer-review

Abstract

To determine the impact of a strategy using enoxaparin for up to 8 days compared with unfractionated heparin (UFH) for 48 h as an adjunct to fibrinolysis for ST-segment elevation myocardial infarction (STEMI) on 1-year clinical outcomes.
Original languageEnglish
Pages (from-to)2097-102
Number of pages6
JournalEuropean Heart Journal
Volume31
Issue number17
DOIs
Publication statusPublished - 2010

Keywords

  • Enoxaparin
  • Heparin
  • Anti-thrombin
  • Myocardial infarction
  • Fibrinolysis

Fingerprint

Dive into the research topics of 'One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial'. Together they form a unique fingerprint.

Cite this